Combination of levetiracetam and IFN- α increased temozolomide efficacy in MGMT-positive glioma

ConclusionsThe combination use of LEV and IFN- α could be an optimal method to overcome TMZ resistance through obvious MGMT inhibition in MGMT-positive glioma.

Source: Cancer Chemotherapy and Pharmacology - October 19, 2020 Category: Cancer & Oncology Source Type: research